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Abstract.  We have isolated a cDNA encoding mouse 
tenascin-X (TN-X), a new member of the family of 
tenascin genes. The TN-X gene lies in the major 
histocompatibility complex (MHC) class HI region, as 
it  is the case for its human counterpart.  On Northern 
blots we detected a TN-X mRNA of "013 kb in most 
tissues analyzed, whereas in various mouse cell lines 
mRNAs of "011 and  13 kb were detected, suggesting 
the possibility of alternative splicing of TN-X tran- 
scripts. We raised antibodies against mouse TN-X 
fragments expressed in bacteria and used these anti- 
bodies to identify the TN-X protein in heart cell ex- 
tracts and in the conditioned medium of a renal carci- 
noma cell line.  The subunit molecular size of TN-X is 
,0500 kD, suggesting that the protein may contain up 
to 40 fibronectin type HI repeats, making it the largest 
tenascin family member known yet. TN-X in condi- 
tioned medium, as well as the purified protein bind to 
heparin,  but no binding to tenascin-C  (TN-C), 
fibronectin, laminin  or collagens could be detected. 
Thus the heparin-binding  activity may be a common 
feature of the tenascins.  The TN-X mRNA as well as 
the protein are predominantly expressed in heart and 
skeletal muscle, but the mRNA is found in most tis- 
sues at a low level. Immunostaining  showed the pro- 
tein to be associated with the extracellular matrix of 
the muscle tissues and with blood vessels in all of the 
tissues analyzed. Although the TN-X gene lies in the 
MHC class HI locus, it is not expressed in the lym- 
phoid organs analyzed, except for the staining  around 
blood vessels. In skin and tissues of the digestive tract 
often a reciprocal distribution of TN-X and TN-C was 
observed. 
T  a~  tenascins  are a  growing  family of extracellular 
matrix proteins.  The first member termed tenascin at- 
tracted attention due to its prominent expression dur- 
ing tissue interactions  in embryogenesis and its overexpres- 
sion in many tumors (12; for reviews see 11, 20). Many im- 
portant functions have been proposed for tenascin based on 
its tissue distribution  and on experimental data from cell cul- 
ture experiments.  Thus, tenascin was suggested to be impor- 
tant in regulating  cell-extracellular matrix interactions  in a 
way to promote cell rounding,  migration  and/or differentia- 
tion. Examples are the development of the central and pe- 
ripheral nervous system (for reviews see 6, 8) as well as many 
instances of  tissue interactions  during organogenesis and cell 
movements in embryogenesis (for reviews see 7-9, 18), and 
in adult life during wound healing (30, 50) or epithelial  cell 
shedding  in the gut (39). 
All of these proposed functions have recently been ques- 
tioned by the apparent well-being  of mice lacking  a func- 
tional tenascin gene (42). Therefore, either tenascin is not re- 
quired for the development of a mouse, or the absence of 
tenascin is compensated for. Since it is assumed that proteins 
which are expressed must have a function somewhere (4), it 
has recently been argued that other tenascin-like  molecules 
could make up for the loss of  tenascin in these knockout mice 
(3,  15,  19, 42).  We therefore decided to investigate  more 
closely other members of the family of tenascin-like  genes, 
which are characterized by being built up of the same types 
of structural  domains,  such as EGF-like repeats,  fibronectin 
type HI repeats and a globular part homologous to fibrino- 
gens.  One of these family members codes for a  protein 
specifically expressed in the central  and peripheral nervous 
system, termed restrictin  in the chicken  (37, 40) and J1- 
160/180 in the rat (21). After the discovery of a third mem- 
ber,  a  tenascin-like  gene  present  in  the  human  major 
histocompatibflity complex (MHC)  ~ class HI locus (3, 23, 
32, 33, 54), Erickson (19) and Bristow et al. (3) suggested 
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tenascin-C  (TN-C;  C  for cytotactin;  29)  for the  original 
tenascin,  tenascin-R  (TN-R)  for restrictin  and tenascin-X 
(TN-X) for the tenascin-like gene of the MHC class UI locus, 
originally described as human gene X  (35).  Recently, evi- 
dence was provided for the existence of a fourth and probably 
more family members yet to be characterized (15). 
Up to now the only knowledge about TN-X was from a 
partial human cDNA sequence (35) and from extensive se- 
quencing of the genomic region encoding the human TN-X 
gene (3, 23,  32,  33).  From the combined data  it could be 
predicted that human TN-X is built up of an NH2-terminal 
domain, followed by four heptad repeats,  18.5 tenascin-type 
EGF-like repeats, at least 29 fibronectin type UI domains and 
a carboxy-terminal fibrinogen domain. Judged  from North- 
ern  blot  and  RNase  protection  data  TN-X  mRNA  was 
reported to be widely expressed with the highest expression 
in muscle and testis (3, 23). 
Since nothing is known about the predicted protein en- 
coded by the TN-X gene, we decided to study the TN-X pro- 
tein in the mouse. We raised antibodies against recombinant 
mouse  TN-X  fragments,  which  were used  to  purify  the 
authentic TN-X protein and to study its tissue distribution  in 
comparison to other extracellular matrix proteins. 
Materials and Methods 
Cell Lines 
The mouse tumor cells,  203 glioma, l~n-Ca (renal carcinoma), RSV-M 
(glioma),  and Colon (colon carcinoma), were generously  provided by Dr. 
Yaglta  (Jyuntendou University,  Japan),  and two  tumor cells,  NFS-Y83 
(fibrosarcoma)  and Sq-1979 (planoepithellal  carcinoma) were kindly pro- 
vided by Dr. Ando (Natl. Inst. Radiol. Sci., Japan) through the RIKEN Cell 
Bank (Tsulmba,  Japan). The other cells were obtained directly from the 
RIKEN Cell Bank (~ulmba, Japan). 2H6GR is a mammary tumor cell line 
established in our laboratory (42).  The culture medium for ali cells was 
Dulbecco's  medium (DME; GIBCO BRL, Gaithersburg, MD) containing 
1095 fetal caif serum (FCS; GIBCO BRL) and the cells were grown at 37°C 
in a humidified atmosphere and 695 CO2. 
cDNA Library Screening and DNA Sequencing 
For the cloning of a short fragment encoding mouse TN-X, reverse tran- 
scriptase/PCR (RT/PCR)  reactions were performed using 10/~g of total 
RNA from thymus of postnatni day 32 (P32) C3I-I/HeN  mice (Charles 
River, Yokohama, Japan). The RT/PCR primers corresponded to sequences 
within the fibrinogen domain of the human TN-X gene. The 5' primer con- 
sisted of the nucleotides  at position 1849 to 1875 and the 3' primer from 
2406 to 2430 according to the sequence presented by (35). The correspond- 
ing sequences of the mouse TN-X are marked in Fig.  1 at nuclentide posi- 
tions 1969 and 2550. The resulting 550-bp fragment was cloned into EcoRV 
digested plasmid vector pBluescript H pKS(-) (Stratngene, La Jolla, CA), 
and the nucleotide sequence was determined with the Sequenase Version 2.0 
Kit (United States Biochemical Corp., Cleveland, OH).  This clone was 
termed pG40. Sutr~equently, a Xtll cDNA library from adult Bnib/c mouse 
heart (Clontech,  Palo Alto,  CA) was  screened with digoxigenin-dUTP 
(Boehringer Mannheim,  Mannheim,  Germany)  labeled IK340. Several 
cDNA clones encompasalng the carboxy terminus of mouse TN-X were re- 
covered and their nucleotide sequences were determined. DNA sequence 
data were analyzed by the Genetics Computer Group (GCG) program ver- 
sion 7.2.  Searches for sequence homology were performed through Gen- 
bank data base (release 76.0, 1993). Sequence comparisons were performed 
on a UNIX computer using the program align in FLAT. 
Northern Blot Analysis 
Total RNA from various tissues of embryonic day 17 (El7), postnatal day 
6 (I'6) and adult mice, as well as from various tumor cells was isolated as 
described (16). 10 ~tg of total RNA was separated  on a 195 agarose/2.2  M 
formaldehyde-denaturing  gel and transferred to Gene Screen membranes 
(Dupont NEN, Boston, MA). The mouse TN-X pG40 and a 2.5-kb TN-C 
probe were used for hybridization (41). DNA probes were labeled with ran- 
dom primers by the DNA polymerase Klenow fragment (Amersham Inter- 
national, Buckinghamshire, England). 
Production of Fusion Proteins in E. coli and 
Generation of  Polyclonal Antibodies 
Two different constructs containing portions of mouse TN-X were made by 
subcloning PCR-generated  fragments into the I~3EX-I or -2 vectors (Phar- 
macia, Piscataway,  NJ) in correct translational reading frame (46).  The 
vector-insertion  junctions were sequenced to confirm correct expression of 
the glutathione S-trausferase  fusion proteins. After induction and lysis of 
the bacteria, fusion proteins were extracted using a series of rising urea con- 
centradon (52).  The fusion proteins are designated as follows. The GST- 
GE800 fusion protein is derived from pGES00 and spans three fibronectin 
type m  repeats at nucleotides 266-1062 (see Figs.  1 and 2). The GST-G40 
fusion protein is derived from pG40 and spans the fibrinogen domain at 
nucleotides 1969-2550.  The pGES00 clone was in addition expressed as a 
fusion protein with a truncated/~-gaiactosidase  as described (52) by modi- 
fication of the commercially available pEX-I (Genofit) (48) resulting in the 
fusion protein/~-gal-GE80O. 
Polyclonal  antibodies were  prepared in chickens against the murine 
TN-X fusion proteins. The fusion proteins (200 ~g per chicken) emulsified 
in complete Freund's adjuvant were injected into the breast muscles.  After 
3 wk, the chickens were boosted with 200 ~tg of TN-X fusion proteins 
emulsified in incomplete Freund's adjuvant.  Antibodies were isolated from 
the egg yolk using sequentiai polyethylene glycol precipitations (22) result- 
ing in the antibody preparations pAb40 and pAb800.  Antibody pAbS00 
(raised against GST-GES00) was affinity purified using/~ogal-GES00  cou- 
pled to CNBr-activated  Sepharose 4B (Pharmacia). The monospecific anti- 
bodies were eluted using 0.1 M glycine/HCl, pH 2.6, and the elnate was im- 
mediately neutralized. 
Western Blot Analysis 
One adult mouse heart was homogenized in 5 mi of 10 mM Tris-HC1, pH 
7.5  containing leupeptin (0.5  #g/rni),  pepstatin (1  #g/mi),  aprotinin (5 
U/H), and 0.25 mM phenylmethylsulfonyl  fluoride (Sigma Chemical Co., 
St. Louis, MO) as protease inhibitors. Homogenates were shaken gently for 
2 h at 4°C, then centrifuged for 15 rain at 8,000 rpm, the pellet re.suspended 
in 20 mM 3-cyclohexylamino-l-propanesulfonic  acid (CAPS), pH 11.0, 150 
mM NaC1, 10 mM EDTA containing protease inhibitors. The suspension 
was extracted for 2 h at 4°C with shaking and centrifuged for 15 rain at 8000 
rpm and the pellet and supernatant were subject to 5 95 SDS-PAGE under 
reducing conditions.  Proteins were tramferred to Immobilon-P transfer 
membrane,  s (Milllpore Corp., Bedford, MA) and immunoblotting was per- 
formed essentially as described (26), with the exception that a chemilumi- 
nescence detection kit (ECL, Amersham) was used to develop the filter. As 
secondary antibody, a rabbit anti-chicken horseradish peroxidase-labeled 
antibody (Cappel Laboratories, Malvern, PA) was used. 
Immunoprecipitation 
Ren-Ca ceils were grown to 8095 confluence in DME/1095 FCS. The condi- 
tioned medium was removed and replaced with 1095 FCS containln~ DME 
without methionine and cysteine  containing 100 t~Ci/ml Tram ssS-label 
(ICN, Costa Mesa, CA). Cells were incubated for 24 h at 37°C, before har- 
vesting the conditioned medium.  Subsequently,  immunoprecipitations of 
the conditioned medium using 2 ~1 of anti-mouse TN-X antibody (pAbS00) 
per 150 #1 of medium were performed and analyzed as described (26) using 
rabbit anti-chicken IgG (Cappol Laboratories) as secondary antibody. 
Purification of  Murine TN-X  from Ren-Ca Cells and 
Binding Studies 
Affinity purified anti-mouse TN-X antibody pAbSO0 (1.5 rag) was coupled 
to 0.5 g of CNBr-activated  Sephamse 413 (Pharmacia) according to the 
manufitcturefs instructions. Conditioned medium from  1 1 of confluent 
Ren-Ca cells was precipita~d with 5095 ammonium sulfate by stirring for 
1 h at 4°C.  After centrifugation for 20 rain at 10,000 rpm, the pellet was 
dissolved in 20 mi of PBS and dialyzed overnight against PBS at 4°C. The 
concentrated sample was centrifuged and passed over a  gelatin-~arose 
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sorbed to the pAbS00-sepharose column. The pAb800 affinity column was 
washed extensively with PBS before eluting the mouse TN-X with 50 mM 
triethylamine, pH 11.0. The proteins (mostly fibronectin) bound to the gela- 
tin-agarose column were eluted with 4 M urea. The fractions containing 
the 500-kD TN-X were analyzed by 5 % SDS-PAGE under reducing condi- 
tions and visualized by silver staining (53). 
The binding of TN-X to other extracellular matrix proteins was done 
using solid phase binding assays. ELISA plates were coated with the follow- 
ing proteins at 100 t~g/ml: fibroneetin (purified from bovine serum by gela- 
tin affinity chromatography), laminin (GIBCO BRL) and acid soluble colla- 
gens type I  and IV (Sigma Chemical Co.)  in PBS.  After blocking and 
washing the coated plates, they were incubated with Ren-Ca cell-condi- 
tioned medium. The binding assay was performed as described for the bind- 
ing of TN-C in conditioned medium to fibronectin coated plates (14). For 
the detection of bound TN-X pAb800 was used. 
For the heparin-binding studies, a column of 0.5 ml of heparin-agorose 
(Sigma Chemical Co.) was used. The column was equilibrated in PBS and 
either 500 #1 of ReCa cell conditioned medium or 100 #1 of purified TN-X 
in PBS (5/~g/ml) was loaded. The column was subsequently washed five 
times with 500 #1 of PBS and then eluted with three times 500 ttl of 1 M 
NaC1 in PBS. 500-t~l fractions were always collected and dilution series of 
each fraction were coated on ELISA plates to quantitate the TN-X present 
in each fraction using the same procedure as we previously described for 
the quantitation of TN-C (38) with the exception of using pAbS00 for the 
detection of TN-X. The absorbances measured and presented in Fig. 8 rep- 
resent relative quantities of TN-X found in the fractions analyzed. 
Immunofluorescence 
Immunofluorescence was carried out as follows. E15.5 embryos, and vari- 
ous tissues of P0, and adult (P32) mice were embedded in Tissue-Tek O.C.T. 
compound (Miles Inc., Kankakee, IL) and frozen. Sections of 12/~m were 
cut at  -200C  and collected on gelatin-coated slides. Sections were in- 
cubated for 2 h at room temperature with anti-TN-X (pAb800), anti-TN-C 
(12), anti-fibronectin (17), or anti-laminin (GIBCO BRL), diluted 200-fold 
in PBS containing  0.1% bovine serum albumin (BSA). The sections were 
washed  with  PBS/0.1%  BSA  and  then  incubated  for  2  h  with  rabbit 
anti-chicken FITC-labeled IgG (Cappel Laboratories), rabbit anti-chicken 
R/'IC-labeled IgG  (Jackson  ImmunoReseareh Laboratories,  Inc.,  West 
Grove, PA),  or goat anti-rabbit RITC-labeled IgG (Cappel Laboratories) 
diluted 500-fold in PBS/0.1%  BSA. 
Results 
Cloning of  a Mouse TN-X cDNA 
Previously,  human  TN-X  has  been  shown  to  be  located 
within "o70 kb centromeric of human steroid 21-hydroxylase 
(CYP21) in the MHC class [] region (3, 23,  32,  33,  35). 
Since many genes located in MHC loci are known to have 
important roles in the immune response, we considered that 
murine TN-X might be expressed in lymphoid organs. Using 
total RNA from adult murine thymus, we performed RT/ 
PCR reactions with two primers derived from the human 
TN-X fibrinogen domain. This resulted in a major product 
of ,o550 bp, the size expected from the known human TN-X 
sequence. This fragment was subeloned and sequenced. The 
sequence of this clone named pC-40 (see Fig. 1) corresponds 
to nucleotide position 1969-2550 in Fig. 2. 
To obtain longer cDNAs of murine TN-X, pG40 was used 
as probe to screen an adult mouse heart eDNA library. Three 
overlapping  clones  encoding  the  860  carboxy-terminal 
amino acids and the Y untranslated region of murine TN-X 
were identified.  A  schematic representation of the TN-X 
eDNA clones obtained is shown in Fig. 1 and the nucleofide 
sequence and the predicted amino acid sequence is presented 
in Fig. 2. The DNA sequence encodes 7 fibronecfin type Ill 
repeats followed by a fibrinogen domain. A poly (A) addition 
I  I  I  I  I  I"  '  '  '  1  I  TGA  IAAA 
Okb  l'kb  2kb  2,77kb 
mTnX1  :  ::  :  :  : 
mTnX2  I  ;  ;;  :  :  : 
;;  :  :  :  :  mTnX3 
266  1062  1969  2550 
I  i  ~EB00  I  I oG40 
pAbSO0  pAb40 
Figure 1. Schematic representation of the TN-X eDNA clones. On 
the top the restriction enzyme map of the 2.77 kb of eDNA se- 
quences covered by the eDNA clones mTnX1, mTnX2, and mTnX3 
(shown below) is drawn.  The coding sequence ends at the stop 
codon IGA as indicated and is followed  by a short 3' noncoding re- 
gion terminating in a stretch of poly A (AAA). The eDNA regions 
subeloned to produce recombinant fusion proteins are indicated 
(pGES00 and pG40). They were used to produce the respective an- 
tibody preparations pAbS00 and pAb40. 
signal (AATAAA) was found at nucleotide 2737-2742 fol- 
lowed by a short poly (A) tail at position 2771. This indicates 
that the clones may cover the complete 3' untranslated region 
of the TN-X transcript. The comparison of this mouse se- 
quence with the sequence of human TN-X (3) revealed an 
87.1% similarity at the amino acid level (Fig. 3), indicating 
that our cDNAs indeed encode the murine counterpart of  hu- 
man TN-X. 
The homology of human and mouse TN-X was further 
substantiated by the homologous genomic location of their 
genes. In humans, the TN-X gene lies on the opposite strand 
of the steroid 21-hydroxylase (CYP21) gene, and its last exon 
overlaps the 3' untranslated region of CYP21 with opposite 
polarity (3, 32, 33). In the vicinity of CYP21, there is a pseu- 
dogene for CYP21  known as CYP21P (51) as well as two 
genes for complement C4.  The gene order is CYP'21  (ac- 
five)-C4B-CYP21P(pseudogene)-C4A, arranged from cen- 
tromere towards telomere (47). The 3' untranslated region of 
CYP21P also contains a sequence which is complementary 
to the 3' portion of a truncated TN-X gene referred to as XA 
(23). In the murine MHC class [] region (S region of the 
H-2 complex, locus site 18.7-18.9 in chromosome 17), there 
is  also  an  active  and  a  pseudogene  for  the  steroid  21- 
hydroxylase (Cyp21), but the relative position of the active 
and pseudogenes is different from that of human (36). The 
order  is  Cyp21ps  (pseudogene)-C4-Cyp21  (acfive)-Slp 
(sex-limited protein variant of C4).  To determine whether 
the mouse TN-X eDNA also arises from the opposite strand 
of the  Cyp21ps  or  Cyp21  gene analogous  to  the  human 
TN-X, we compared the 3' sequence of mouse TN-X with 
the known Cyp21ps and Cyp21 gene sequences (Fig. 4). The 
3' region of murine TN-X shows high similarity to cCyp21ps 
(complementary sequence of the 3' untranslated region of 
murine Cyp2  lps) with 96.8 % identity at the nucleotide level, 
and it contains a Cyp21ps-specific 30-bp insertion at nucleo- 
fide position 2614-2643 of TN-X. In contrast the same re- 
gion of mouse TN-X shows only 93.6 % identity to cCyp21 
(complementary sequence of the 3' untranslated region of 
murine Cyp21). Thus, the mouse TN-X gene also appears to 
be located in the MHC class [] locus. At present, we can 
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GAAT  TCG ACTC TTTCTTAGTCCAGT AC  JUtGAACN;GGG  AGGGCAGGTCC AGG TCG TGL'T ~~  ~  G ~  ~  ~  CA~ ~C  ~  ~  ~CC~  T~  ~  T~  ~ 
[  ]~.IV 
41  F  L  L  F  G  L  I  G  L  K  R  L  G  P  V  S  V  g  G  T  T  &  P  V  E  K  T  P  Q  P  R  L  G  E  L  S  V  T  E  E 
121 TTCC  TGCTCTTCC-GCCTCATAGGCC  TCAA&CGGCTGGGGCCTGTC  TCCG~AGGGCACC~CCG~A~&C~C~C~GG~  ~TG~AG~G~ 
81 T  S  D  S  M  B  L  S  W  S  V  &  0  G  P  F  D  S  F  L  V  Q  Y  K  0  R  D  G  0  L  O  T  V  S  L  &  k  D  O  R 
241 ACCTCTGACTCCATGC&CCTCTCTTGGTCTG  TC~CCAGGGTCCC  TTTGACTCCTTCCTGG~T~A~A~&~C~TCCT~  ~C~CGA 
121 E  V  T  I  E  G  L  Q  P  G  R  K  Y  K  F  L  L  ¥  G  L  T  G  G  X  R  L  G  G  I  S  A  L  G  V  T  A  S  E  V  D 
361 GAGG  TCACCATAGAGGG  TCT&CAGC  C  AGGCAGGA/~TACAAGTTCC  TGC  TC  T  &TG  GGC  TCAC  TGGAGGG~C  ~G  ATC  ~ T~C ~G~  ~AC ~  C  ~ ~ ~G ~G~ 
161 I  S  &  P  D  H  T  E  P  P  H  iq  P  G  L  G  T  L  A  V  T  E  &  T  P  D  S  L  R  L  S  ~  A  V  A  R  G  P  F  D 
491  AT&TCAGCCCCAGACCACACTGAC-CCCCCTC  ATGCTCCCGGCCTGGGGACGC  ~C~TG~A~CCC~T~T~G~C  ~C~C~G  ~CCCC~ 
201 S  F  V  V  0  Y  O  D  T  E  g  g  T  0  A  L  L  V  D  G  D  0  D  K  V  L  I  S  G  L  E  P  K  T  S  ¥  K  P  F  L 
601 TCCTTTG  TGGTCCAG  TACC  AGGACACAGAGAATGA~ CCAGGCCCTGC  TTG  TTG  ATGG~ACC  ~G~  ~  ~C ~ A  ~  ~G~CC A~CTAC  ~G~  T~ C~ 
241 y  G  L  R  E  G  T  R  H  G  P  V  S  V  E  G  T  T  D  P  V  P  A  G  0  G  P  G  D  P  G  P  R  L  S  0  L  S  V  S 
721  TAI'GGCC TCCG 1'G/~qGGG AC&CGCC ACGGACCTGTG TC TGTAGAGGGCACCACAG  ATCC  ~T  ~C  ~  ~  ~C C~  ~CCCC  ~c  ~  ~  A~  ~  ~  ~  ~  ~  & 
281  D  V  T  T  $  $  L  g  L  N  W  g  A  P  L  G  D  F  D  $  F  Q  L  R  F  G  V  P  L  L  S  T  L  g  O  N  P  R  T  L 
841  G &'/'G  TGACCACCAG TTCTCTGCGGC  TA&ACTGGG&AGC CCCGCTTGGGGAC  TT'IG~  ~  C T&C~ T~  ~  ~CC ~T~  T~ ~  ~  ~  ~  TC ~ 
321 Q  0  R  g  L  M  V  P  G  V  R  P  S  &  M  L  R  D  L  R  P  G  T  L  Y  S  L  T  L  ¥  G  L  R  G  P  H  K  A  D  S 
981  C  AAC  AC~  GAG~T  TATGGTGCC  AG  GCG  T~ GG~GTC  CG~ ATG  C  TCC  GC~  ACC  T~G TCC  TG~ ~C C  ~T ATA~C  ~  ~ TGTAT~C~G~  C~ ~  ~  ~  ~ 
[  RXVII 
361 I  O  G  T  A  R  T  L  S  P  V  L  £  S  P  R  D  L  0  F  S  D  I  G  g  T  S  A  K  V  K  W  V  P  P  T  S  R  V  D 
1081  ATCCAGGGCAC  TGCCCGCACACTCAGCCCAGTTCTGGAGAGCCCCCGGGACC  TGC  AATTCAGCG~  A~CATC~C~  ~C~C~G~C~G~G~ 
401 S  F  K  I  S  Y  0  L  &  D  G  G  E  P  Q  S  V  (]  V  D  G  R  T  0  T  0  I  L  O  G  L  I  P  D  T  g  Y  g  V  T 
1201  AGCTTC&AAATCTCCTACC/~CTAGCAGATGGAGGAGAGCCACAAAGTG  TGC  AGG  TGGATGG~CC~ACCC~A~CTCCA~C~A~C~AC~GCTA~G~T 
[  ~VZZZ 
441 V  V  S  V  R  G  F  E  E  £  g  P  L  T  G  F  L  T  T  V  P  D  G  P  T  Q  L  g  A  L  g  L  T  D  G  S  A  L  L  H 
1321  GTGG  TCTCCGTCCG  TGGCTTTGAGGAAAGCGAGCCTCTCACAGGC  TTCC  TCACCACAGTGCC  ~A~AC~ T~G~AT~ ~AC~  ~GGA~  ~CCTTCTAC~ 
481 M  K  P  P  H  K  P  V  D  K  Y  D  V  V  E  P  G  k  P  L  Q  A  S  k  P  G  S  k  V  D  Y  P  L  D  L  A 
1441  TGGAAAcCCC~CCAC/u~C&GTGG~AAATATGA~GTCGA~GTCGAATCC~CTGGGGC~C~ACCCCTTCAGG~CTCAGC~C  ~C~TG~T~C~TG~ ~C~A 
[  ~tlX 
521 L  D  T  g  Y  T  &  T  V  R  G  L  g  G  P  g  F  T  S  P  A  S  I  T  F  T  T  G  L  K  P  P  Q  D  L  E  A  K  E  V 
1561 CT~ACA~AATTACACAGCC~GTC~GTGGTCTCCGGGGTCCTA~TTCACCTCC~  AC~CAGCATA~CT~A~AC~GTT~C~  CCCC~  ~T~A~C~G~G~ 
561 T  P  R  T  A  L  L  T  N  T  E  P  E  V  P  P  T  G  Y  L  L  S  F  D  T  P  G  O  Q  I  (]  E  I  L  L  P  A  G  T  T 
1681  ACTCCTC~ACC~CCTGCTCACTTC,  GACTOAGCCTGAAGTCCCACCCAC~T~T~TC~G~ACCCC~AGAT~G~C  ~C~A~ ~C 
] 
601 S  H  R  L  L  R  L  F  P  S  T  F  Y  S  A  Q  L  R  A  I  W  G  E  S  L  T  P  P  V  L  T  S  F  T  T  G  G  O  g  I 
IB01 TCGC~AC~TTCT~C, CCTCTTCCCCTCCACCTTCTAC&GTGCCCAGCTGCGGGCCATCTGC~G~C~AC~C~CCG~  ~T~CTTT&CT~C~A~ 
641 P  F  P  g  D  C  G  E  g  L  K  N  G  P  S  A  S  K  T  T  T  I  F  L  N  G  N  g  g  R  P  L  D  V  F  C  D  M  E  T 
1921 CCCTTCCCCCGGG&CTGTGGGGAGGAGCTGAAGA&TGGC,  CCCAG~CTCAAAGACC~C~C&~  ~C~&&~A~CG~CCT~  A~T~A~G~ ~T 
....................... 
681 D  G  G  G  W  L  V  F  O  R  R  M  D  G  O  T  D  F  M  R  D  W  g  E  Y  &  H  G  P  G  g  I  S  G  g  F  N"  L  G  N 
2041  GATGG&GG  TGG  TTGGC  TG  GTG  TTCC  AGCGCC  GCATGGA  TGGACAG  ACGG  AC  T  TCTGG/g~AGAC  TGGGAGG&GT  ACGCCC  ATGG  TTTTGGG  AAC  ATTTCCGGGG  A&TTC  TGGC  TGGGC  AAC 
721 g  A  L  H  S  L  T  O  A  G  D  Y  S  L  g  V  D  L  R  A  G  K  E  k  V  F  &  O  ¥  D  P  F  R  V  D  S  &  K  g  N 
2161 G  AGGCCC  TGCAC  AG  CC  TAAC  AC  AGGC  TGGAG  ACT&  TTC  TC  TG  CG  TG  TGG  ACC  TGC  GGGC  CGG  AAAGG/O,  GCCG  TGT  TCGCCC  AG  T&  TGAC  TTC  TTCC  GTG  TAG  AC  TC  AGC  AAAGGAG  AAC 
761 Y  g  L  H  L  g  G  Y  H  G  T  k  G  D  S  g  S  ¥  H  S  G  S  V  F  S  k  g  D  R  D  P  N  N  L  L  I  S  C  &  V 
2281  T  AC  C  GCC  TACACC  TTGAGGGC  TACC  ATG  GGAC  TGC  AGGCG  AC  TC  TATGAGCTACC  AC  AG  TGGC  &GTG  TC  TTTTC  TGCCC  G  TG  A  TCG  AGAC  CC  C  AAC  &ACT  TGC  TCATC  TC  TTGC  GC  TG  TC 
801 S  Y  g  G  &  W  W  ¥  R  g  C  H  Y  &  N  L  N  G  L  ¥  G  S  T  V  D  H  Q  G  V  S  W  Y  H  ~  K  G  F  E  F  S 
2401  TCTT  ATCGTC-GGGC  TTGG  TGG  TAC  AGGAACTGTCAC  TACGCC/U~C  C  TC  AATGGGC  TC  TATGGGAGC  ACAGTGG  ATC  ACC  AGGG  AG  TGAGC  TGG  TACC  AC  TGGAAGGGC  TTCG  AG  TTC  TCT 
841 V  P  F  T  E  M  K  L  g  P  g  N  F  Q  V  P  T  R  G  T  * 
2521  G  TGC  CCTTC  ACGGAAATG  A/~GC  TGC  GAC  CCAGAAAC  TTCC  AGG  TCCCCACC  AGGGGCAC  C  TG  AGCC  TGC  TGCCC  ACC  TC  AC  TC  AC  &CCCC  GG  TATGAC  TG  CCG  &GCAC  TG  AGGG  GTTGTG 
•  ,91  ...................... 
2641 CCC  &GAG  AAGAGCC  AGCATGCC  &CACC  AAGG  AGGC  CTTCTC  TOCC  AC  AATC  TCAC  AGCACCATGTTTAC  AGGGGGGGAGGGG  &GGGG  AAA  TGG  AGC  A  &T&AaGGAGAAAC  TGAGGC  ACTA 
27~I GGCTCATCCTAn 
Figure 2. Nucleotide and pre- 
dicted protein sequence of the 
carboxy-terminal  region  of 
mouse TN-X.  The TGA stop 
codon is marked with an as- 
terisk. The typical AATAAA 
polyadenylation  signal is un- 
derlined.  The  poly  (A)  tail 
following the last base is des- 
ignated  (A)n.  Potential  sites 
for N-linked glycosylation are 
indicated by bold letters. This 
sequence  contains  6.5  fibro- 
nectin type m  repeats marked 
XXIII-XXIX accordin~ to the 
numbering used  for  the  hu- 
man TN-X by (3), followed by 
a  fibrinogen  domain-labeled 
FG. ~  within the fibrino- 
gen domain mark the primer 
positions used to amplify pG- 
40  and  thus  bracket the  se- 
quence contained in the fusion 
protein GST-G40 and the ar- 
rows  within  the  fibronectin 
type HI repeats mark the pri- 
mers used to amplify the clone 
pGE800 and thus bracket the 
sequence of the fusion protein 
OST~F~00 and O-gal-O~00. 
These sequence data are avail- 
able  from  EMBL/GenBank/ 
DDBJ under accession num- 
ber X73959. 
only speculate about the reason why the 3' region of murine 
TN-X does not match exactly either the published cCyp21ps 
or cCyp21  (see Discussion). 
Expression Pattern of  Murine TN-X Compared with 
That of TN-C mRNA 
Northern blot analysis was performed to study the size and 
tissue distribution of TN-X transcripts (Fig. 5 A). As probe 
we used pG40.  No cross-hybridization among members of 
the TN family was detected under the conditions used. A ma- 
jor TN-X transcript was expressed ubiquitously in most tis- 
sues, with the highest expression in heart, skin, and skeletal 
muscle of El7 and 1)6 mice. The size of the mRNA detected 
could be roughly estimated to be ,~13 kb or larger.  Due to 
the need for long exposure of the blot background staining 
of the 28 s RNA occurred. We can, however, not exclude that 
we  are  in addition detecting  much  smatler  transcripts  or 
breakdown  products.  The  expression  pattern of TN-X  in 
adult mice was similar to that of 1)6 mice (data not shown). 
A TN-C probe for comparison hybridized to two major tran- 
scripts  at 7  and 5.5  kb  and is predominantly detected in 
brain, thymus, and lung during early developmental stages 
(Fig. 5 B), and is drastically downregulated in most tissues 
except  for  thymus  in  adult mice  (data  not  shown).  The 
smaller transcript represents an alternatively spliced TN-C 
The Journal of Cell Biology, Volume 125, 1994  486 i EFDSFLVQYKNRGGQVQWPAAADQREVT  I  S  S  LE  PNRKYRFLLFG  L  IGLKRI~  pVSVEGTTAPVEKT  I~  PRLGELS~TEETSDSI~ILSWSVA~  P~S F  L 
IIIIl:llll:::l.:llll.ll,lllll,  .lll.lllllll:ll  I  tllll:l.::llll:ll..l:llll.l.llll.l::lll.lllllllll: 
2764 EFDS  FVVQ~RLQVVPVAANQREVTVQALE  p  SRKYRFLLYGLSGRKRLG  p  I  SADSTTAPLEKEL  P  PHLGELTVAEETS  S  SLRLSWTVA~  P~  ~ 
101 VQYKDRDGQLQTVS  LAADQP.EVT  I  ~GLQ  PGRKYK  FLLYGLTGGKRIA~  I  SALGVTAS  EVDI  S  ....  API~TE  P  PHAPGLGT  LAVTEAT  PDSLRLSWAVAR 
II1:1  Ill  ..I.:11111.11:1:1:11:111111111  IIIIIl.:llll:ll.I  I..  I:  .111..I  II.l.ll:.llll:llll.ll. 
2864 VOYRDTDGQPRAVPVAAD~RTVTVEDLEPGKKYKFLLYG  r  .LGGKRLG  PVS  ALGMTAPEEDT  PAP  ELApEAP  B  P  PEg  PRLGVLTVTDTT  ~AQ 
197 GPFDSIrv'VQy~ALLVDGDQDKVL  I  SGLE  PKTSYKFF  LYGLREGTRHG  PVSVEGTTDPVPAGQGPGDPG  ~Q  L~S~SS  ~ 
llllllllll:ll:.:.lllllllll.l:lllllll.l.l:l:llll:ll.l  II:I.IIII:  .I  I1..::.  llllllll.llllllllllllll  l 
2964 GPFDS  FVV~YEDTNGQ  PQALLVDGDQS  K  I  L  I  SGLE  PST  PYRF  LLYGLMEGKRLG  P  LSAEGTTGLA  PAGQT  S  EE  SRPRLSQLSVTDVTT  S  S  LRLNWEAP  ~ 
297 DFDS  FQLRFGVPL  L  STLEQNPRTLQQRELMVPGVRPSAMIA%DLRPGTLYS  LTLYGLRG  pHKADS  I  QGTARTLS  PVLES  PRDLQFSDIG~  S  ~P ~ 
• 1111  IIIIII  III1.:11.1  IIIIIII1.1.11:11111.1111111111111111111111111111111111111111:1  IIIII1.1:11. 
3064 AFDSFLLRFGVPSPSTLEPHPRPLLQRELMV~GTRHSAVLRDLRSGTLYS  LTLYGLRG  PHKADSI  QGTARTLS  PVLESPRDLQFSEIRETSAKVNWMpPP 
397 SRVDSFKI  SYQLADGGEPQSVQV~GRTQTQI  LQGLI  PDTRYEVTVVSVRGFEESEPLTGFLTTVpDGPTQLRALNLTDGSALLHWK  PPHK  PVDKYDVEVE 
I1.1111:11111111111111111...11  IIIII1:.111111111111111111111111111  IIIIIIIII1:1  I.'111111:.111.11::1. 
3164 S  RADS  FKVSYOLADGGE  PQ  SVQVDGQARTQKLQGL  I  PGARY  EVTVVSVRG  F  EES  E  P  LTGFLTTVPDG  pTQLRALNLT  EGFAVLHWK  P  PQN  PVDTYDI  Q~ 
497 S  PGAPPLQASA￿GSAVDYPLTDLALDTNYTATVRGLRGPNFTS PASITFTTGLKP  PQDLEAKEVTPRTALLTWTEPEVP~YLLS~  I  QEI  LLP 
.IIIIIIII..IIIIIIIII  II.I.IIIIIIIIIIIIII:IIIIIIIIIIII.:I.IIIIIIIII  IIIIIIIII.I.I.IIIIII.IIIII  IIIIII 
3264 APGAPPLQAETPGSAVDypLHDLVLHTNYTATVRGLRGPNLTS  PAS  ITFTTGLEAPRDLEAKEVTPRTALLTWTEP  PVRPAGYLLSFHTPGGQNQEI  LLP 
597 AGTT  SHRLLRSF  PS  TFY  SAQ  LRAIWGE  S  LT  P  PVLT  S  FTTGGQRI  P  F  PRDCGE  ELKNG  P  SAS  KTTT  I  FLNGNRERPLDVFCEIfETDGGGWLVFQRRMDGQT 
:l.lll.tl  tllll  I.l.l.l:ll:ll  III  IIIIIII  IIIIIIIIIIl:.ll::ll:l.  II  IIIIIIlll:lllllllllllllllllllllll 
3364 GG  I  T  SHQLLG  DF  PS  T  SYNARLQAMWGQ  S  LL  p  PVST  S  FTTGGLRI  PF  PRDCG  EEMQNGAGAS  RTST  I  FLNGNRERp  LNVFCI~METDGGGWLVFQRRMDGQT 
697 DFWRDWEEYAHGFGN  I  SGEFWLG~EALHS  LTQAGDYS  LRVDLRAGKEAVFAQYDFFRVDS  AK  ENYRLH~EGYHGT~D~  ~  SG~  S~ L  I 
IIIIIII:IIIIIIIIIIIIIIIIIIIIIIIIIIIII:IIIIIII.IIIIIIII  I:1111  I II  IIIIIIIIIIIIIIIIIIIIIIIIIIIII.III 
3464 DFWRDWEDYAHGFG~  I  SG  EFWLGN  EALH  S  LT  QAGDy  S  I  RVDLRAGDEAVFAQYD  S  FHVDS  AAEYYRLHL  EGYHGTAGDSMSYHSG  SVF  SARDRD~S  ~L  I 
797 S  CAVSYRGAWWYRNCHYANLNG  LYG  S  TVDHQGVSWYHWKGF  EF  SVPFT  EMK  LR  pRNFQVPTRGT 
lllllllllllllllllllllllllllllllllllllllllllllllllllllllll-  I.  I. 
3564 S  CAVSYRGA~qYRNCHYANLNG  LYGSTVDHQGVSWYHWKGFEF  SVPFTEMK  LR  pRNFRS  PAGGG 
Figure 3. Sequence alignment 
of the carhoxy-terminal region 
of ~mse (upper sequence) and 
human TN-X (lower sequence). 
Amino  acid  sequences were 
aligned  using  the GCG pro- 
gram bestfit. Vertical bars rep- 
resent identical  residues  and 
dots indicate conservative sub- 
stitutions.  The numbering  of 
mouse TN-X  is  from Fig.  1 
and the sequence and number- 
ing of human TN-X is taken 
from (3), except for the inclu- 
sion ofa glutamic acid at posi- 
tion 3359, which was present 
in a cDNA clone of TN-X pre- 
viously reported by the same 
authors (35). Dashes in human 
TN-X  indicate insertions to 
maximize homology. 
mRNA. This confirms previous results on TN-C expression 
(41). 
In contrast to the expression in tissues, which showed a 
single mRNA band around 13 kb, there existed two distinct 
transcripts of TN-X in some tumor cells (Fig. 6 A), namely, 
a ool3- and an  ll-kb transcript.  The large form was espe- 
cially prominent in mouse glioma 203 and renal carcinoma 
Ren-Ca cells, whereas the small form was found in MethA 
sarcoma and RSV-M glioma. For comparison the expression 
pattern of TN-C is shown in Fig. 6 B, confirming our previous 
data (41).  No correlation between the expression levels or 
splicing patterns of TN-X and TN-C, respectively, can be ob- 
served in the cell lines analyzed. 
Identification and Purification of the TN-X Protein 
To identify the presence of TN-X protein in mice, Western 
blot analysis of crude homogenates of mouse adult heart was 
carried out using the polyclonal antibody pAb40 prepared 
against a GST-TN-X  fusion protein.  On immunoblots, the 
antibodies recognized a band of oo500 kD in the pellet, but 
not in the supernatant following CAPS extraction (Fig. 7 A). 
This molecular size correlates well with the predicted pro- 
rein subunit  size based on the length of the TN-X mRNA. 
This result indicated that TN-X is present in the heart, but 
not extractable without denaturing  and reducing agents.  We 
thus attempted  to use cultured murine cells to purify TN-X 
protein. 
Based on the presence of TN-X mRNA on Northern blots 
(Fig. 6 A), renal carcinoma (Ren-Ca) cells were considered 
as a source for the purification. The release of TN-X by these 
cells into the conditioned medium was explored by immuno- 
precipitation analysis with affinity-purified  TN-X antibody 
pAbS00. This antibody precipitated from medium of meta- 
bolically  labeled  Ren-Ca cells  a  single  500-kD  molecule 
(Fig. 7 A). To isolate TN-X from conditioned medium of un- 
labeled cells, we prepared an affinity  column coupled with 
anti-TN-X antibody pAb800. This column allowed us to pu- 
rify a single molecule migrating at oo500 kD (Fig. 7 B), con- 
sistent with the immunoblotting  and immunoprecipitation 
results. When the purified TN-X was run under nonreducing 
conditions it did not enter the gel (not shown), suggesting 
cO]p21ps 
YN-X 
cCylP21 
2692  ~'lUb"2~  .~~"IcfG~O~I~~GGT 
IIIIIIIIIIIIIIIIIIIIIIIII  IIIIIIIII  IIIIII  IIIIII IIIIIIIIII  IIIII  III  IIIIIIIIIIII 
2482  GG~G~%GCY61G'I~CCAC'I~GI~IG  .............  O~'C~,-~vX~'I~"CC~OGM~'ITLI~G~..OL-'G.I~CC.CAG.I~I~I~CAGGT 
IIIIIIlllllllllltllllllll  IIIIIIIIII  IIIIIfllllllllllllllllllll  II  It  III  tlIIIIIIIII 
3038  OGAO'J~O.~'I~G'I~  .............  OCTI~G.M~'vv~u~'~GCCC'ITCA~TCJO, GCT..CCG~-'C.CJ,  D.~T'I~GGC 
2792  .  ~  'I~TGAC'I~'~C~CA  .a~  CCAGAGKAGAGCC,t~?~'I~CCI~ 
~~~i~I~i~1~ii~1~i~~I~ 
2565  _  .CC"I~.~"TCJ~CCCC~IWIUAC'IGCCC~GC.~C~~_~G.~ICC~CA'IUCC2~ 
IIIIlllllll  IIIIIIIIIIIIIIllt  IIIIltllllllllll  II  IIIItltllltl  I  IIII  I 
2955  CCCCI~'CAGGG.~~~CCCi~T  ..............................  AG~GN~G~GCCItCCG'I~CC~: 
2693  ~'C~rIC'I'TT  'I'GGN3CAATI~AAGGAG  T  2598 
lllllllllllllllllllllllllllllllllllllll  IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII  IIIIIIIII 
2665  ~'I~IUCCz~CJU~'I~ACA~2It£~..A'L~-~-v~"  2~A'Z~?,AO~Ut~.T~,CI~OCJ~T  2759 
Ill  IIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIII  IIIII  llllll  IIII IIIIII I  IIIIIIIIIIIIIII  I  I 
2886 ~2G4tGG.~  'I'~"~I~ACAGCACCATCT~AC..QOI~GCG~QQ~*I~..,.CAA~.TTPA..AI~  2800 
Figure 4. Comparison of the 3' 
region of the mouse TN-X se- 
quence  with  complementary 
sequences  of the  3' untrans- 
lated region of mouse genomic 
Cyp2tps (cCyp21ps) and Cyp- 
21 (cCyp21).  The complemen- 
tary sequences of Cyp21ps at 
nu¢leotide  position  2598- 
2892 (available from EMBL/ 
GenBank/DDBJ under acces- 
sion number M15008) and of 
Cyp21 at 2800 to 3038 (accession number M15009) are shown and compared with the mouse TN-X sequence from nucleotide position 
2482-2759.  Vertical lines between nucleotide sequences indicate  identity between sequences.  Dots in cCyp21 and cCyp21 are inserted 
to maximize homology to TN-X. The termination  codon at 2581-2583 and polyadenylation  signal at 2737-2742 of TN-X is shown with 
hold letters or underlined,  respectively. 
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of TN-X transcripts  in com- 
parison to TN-C. Total RNA 
was prepared from various tis- 
sues Of  E17 and P6 mice. Sam- 
ples were subjected to RNA 
blotting.  (A)  The  filter  was 
probed with the TN-X pG40. 
A •13-kb  band indicated with 
an arrowhead  is observed  in 
most tissues.  The position  of 
the  28S rRNA is  indicated.  (B) 
After  removal  of the TN-X 
probe  the  same  membrane 
was  probed for  TN-C mRNA. 
The 7-  and 5.5-kb  TN-C tran- 
scripts  are indicated  with open circles.  Cross-hybridization  of  the 550-bp TN-X probe with rRNAs was reproducibly higher than that  of 
TN-C. This may relate  to  our  previous finding  that  the  G+C%  level  of  TN-X is  higher  than  that  of  TN-C (28).  The star  in  the  cerebellum 
lane of  El7 indicates  that  no RNA  was loaded. 
that the protein is a disulfide-linked oligomer like all other 
known members of the tenascin family. Taking these data to- 
gether, we conclude that the 500-kD protein is indeed the 
subunit of TN-X and that it is secreted into the conditioned 
medium of Pen-Ca cells. 
TN-X Is a Heparin-binding Protein 
It is known that TN-C interacts with other extracellular ma- 
trix components, most notably with TN-R (40), fibronectin 
(13, 14), heparin (7, 31) and proteoglycans (5, 27). We there- 
fore tested whether TN-X also interacts with other compo- 
nents of the extracellular matrix. We examined the binding 
of TN-X present in conditioned medium of Pen-Ca cells in 
solid phase binding assays to TN-C, fibronectin, laminin, 
and  collagens  type  I  and  IV,  but  could  not  detect  any 
significant binding to any of  these proteins (not shown). Next 
we investigated whether TN-X binds to beparin. In the first 
experiment, conditioned medium of  Pen-Ca cells was passed 
over a heparin-agarose column. The flow through, the wash, 
and the high salt eluate fractions were collected and analyzed 
by ELISA for the presence of TNoX, revealing that most of 
the TN-X present in the loaded conditioned medium was re- 
tained by the column and could be eluted by 1 M NaCI (Fig. 
8).  Since this  binding  could have been indirect,  we also 
tested whether the purified TN-X binds to heparin-agarose. 
The same experiment was repeated by loading purified TN-X 
in PBS onto the beparin-agarose column. Again most of the 
TN-X was retained by the column and could be eluted by 
high salt (Fig. 8). Therefore, the beparin-binding activity ap- 
pears to be shared by both TN-C and TN-X. 
Figure 6. Detection  of  TN-X transcripts  in  mouse cell  fines.  (A)  To- 
tal  RNAs from various  cells  were subjected  to  RNA  blotting  as  de- 
scribed.  The  blot  was  hybridized  with  pG40. The TN-X transcripts 
of  13 and II kb are  indicated  with arrowheads. (B) Expression of 
mouse  TN-C  was investigated  using the same membrane  after 
removal  of  the  TN-X probe.  The  7-  and  5.5-kb  TN-C transcripts  are 
indicated  with open circles.  Position  of  28S rRNA  is indicated. 
Figure 7. Identification and purification of  the mouse TN-X protein. 
(A) Immunological detection of TN-X by Western blot analysis 
(lanes 1 and 2) and by immunoprecipitation (lane 3). Adult heart 
homogenates were used for the immunoblots using the TN-X-spe- 
cific antibody pAb40. After CAPS (pH 11.0) extraction, the pellet 
(lane 1)  and supernatant (lane 2) were resolved by SDS-PAGE, 
blotted onto a membrane, and immunostained with pAb40. 20/~g 
of protein was loaded in each lane. A ~500-kD band,  indicated 
with an arrowhead can be detected in the pellet fraction. Immuno- 
precipitation of TN-X from conditioned medium of metabolically 
labeled renal carcinoma (Ren-Ca) cells using TN-X specific anti- 
body pAb800 revealed a 500-kD band indicated by an arrowhead 
(lane 3). (B) A silver stained gel shows the affinity purification of 
TN-X using immobilized pAbS00. Lane 1 represents the crude con- 
ditioned medium loaded sequentially onto a gelatin agarose and 
pAb800 column; lane 2 represents the flow  through; lane 3 is the 
eluate from the gelatin-agarose column (mostly fibronectin); lanes 
4-6 are three eluate fractions of the pAbS00 column and represent 
the 500-kD subunit of the purified TN-X protein indicated by an 
arrowhead. Molecular size markers for 450 (non-reduced fibronec- 
tin dimer) and 200 (myosin) kD are indicated with bars. 
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Figure 8. TN-X binds to heparin. Conditioned medium (CM) of 
ReCa cells was passed over a heparin-agarose column and the TN-X 
present in the loaded medium (L), the flow through and wash frac- 
tions (F/, F2), and the eluate fractions (E/, E2) was determined by 
ELISA, showing that most of the TN-X loaded was retained by the 
column and was recovered in the eluate using 1 M NaCl. The same 
type of experiment was performed using purified TN-X and the 
amount of TN-X loaded (L), present in the flow through fractions 
(F/, F2) and the eluate fractions (E/,//:2)  determined by ELISA, 
Again most of the TN-X was quantitatively retained by the heparin 
column and could be recovered in the  I M NaC1 eluate. 
Tissue Distribution of TN-X Protein 
The distribution of TN-X protein was examined in various 
tissues and compared with other well-characterized extracel- 
lular matrix proteins. In brain, lung, and mammary gland we 
could not find any significant staining. Serial cryosections of 
mouse heart and skeletal muscle of  E15.5, P0, and adult mice 
were stained by indirect immunofluorescence with preim- 
mune IgG, anti-TN-X (pAbS00), anti-TN-C, anti-fibronec- 
tin, or anti-laminin antibodies. Preimmune IgG did not show 
any staining (data not shown). TN-X was present at all stages 
examined along skeletal muscle fibers (Fig. 9, d and f) and 
cardiac muscle cells (Fig. 9, b and h), typical for extracellu- 
lax matrix staining. Fibronectin and laminin were abundant 
in a  fine fibrillar distribution,  in contrast to TN-C which 
could not be detected in the heart and skeletal muscle at any 
developmental stage examined (data not shown). 
Interestingly, in skin and digestive tract, especially esoph- 
agus, gut, and stomach, the distributions of TN-X and TN-C 
were shown to be distinct and nearly reciprocal (Fig.  10). 
For  instance,  in  E15.5  esophagus  TN-X  was  abundant 
within the lamina propria (Fig.  10 g), whereas TN-C was 
prominent in the surrounding smooth muscle (Fig. 10 m). In 
gut and stomach, TN-X was most prominent in the mesen- 
thyme surrounding smooth muscle (Fig.  10,  i, j,  and k), 
while TN-C was mainly expressed within the smooth muscle 
and  in the dense mesenchyme adjacent to the epithelium 
(Fig.  10, p  and q). In skin, TN-X was abundant throughout 
the dermis and the staining is fading towards the epidermis 
(Fig. 10 l), whereas TN-C was most intensely stained adja- 
cent to the epidermis and the staining is fading out into the 
dermis (Fig.  10 r).  It is interesting to note that the TN-C 
staining in E15.5 esophagus is disappearing until P0 and the 
TN-C  expression in the  gut is  induced in the  same  time 
Figure 9. Distribution of TN- 
X in murine heart and skeletal 
muscle. Sections of adult heart 
(g and h), adult skeletal mus- 
cle (e and  f), E15.5 fetal heart 
(a  and  b),  and  P0  skeletal 
muscle (c and d) were stained 
with hematoxylin  and eosin (a, 
c,  e,  and g),  TN-X  specific 
antibody pAb800 (b, d, f, and 
h). Bar, 50 #m. 
Matsurnoto et al. Purification  and Distribution of Tenascin-X  489 Figure 1£1  Reciprocal stainln~ patterns for TN-X and TN-C in the digestive tract and skin.  Sequential sections of E15.5  (a, g, and m) 
and P0 (b, h, and n) esophagus; E15.5 (c, i, and o) and PO (d,j, and p) gut; E15.5 stomach (¢, k, and q) and skin ~  l, and r) were stained 
with hematoxylin and eosin (a-f), TN-X antibody pAbS00 (g-l) or anfi-TN-C antibody (m-r). Triangles indicate areas where TN-X is 
prominently expressed but not TN-C, whereas circles mark areas of strong TN-C but not TN-X expression. An arrow in p shows primitive 
villi that consist of  the mesenchymal core (lamina propria), which is covered by epithelial cells. In contrast to TN-X, TN-C is predominandy 
found in the lamina propria, as previously shown by 1. c, cartilage; e, epithefium; d, dermis; h, hair follicle;/p, lamina propria; m, mesen- 
chyme; sm in b, skeletal muscle; sm in d, smooth muscle; t, thymus; ton, undifferentiated mesenchyme. Bar, 50/zm. 
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during this period of development. 
To determine whether TN-X is produced in lymphoid  cells 
such as T and B lymphocytes, immunofluorescence  of Peyer's 
patches of the ilium and of spleen was performed. PeTer's 
patches are composed of densely packed lymphocytes  (mainly 
B  lymphocytes) that differentiate into plasma  cells  upon 
appropriate antigenic stimulation. TN-X was exclusively co- 
localized with capillaries in the nodules and thus is unlikely 
to be produced by lymphocytes (Fig. 11). This staining pat- 
tern was similar to the other extracellular matrix proteins 
fibronectin and laminin (not shown). In the spleen as well, 
TN-X  was only prominent around the central artery and 
other arterioles and veins, but not within the tissue contain- 
ing T- and B-lymphocytes (not shown). These results indi- 
c.ate that TN-X is not produced in lymphoid cells. 
Also in other organs such as the liver and the kidney TN-X 
was found associated with blood vessels such as arteries, ar- 
terioles, veins, and capillaries (Fig. 11). In the liver, the wall 
of the central vein, consisting of endothelial cells supported 
by  a  sparse  population of collagen fibers,  was  intensely 
stained by anti-TN-X antibody (Fig. 11 b). On the contrary, 
fibronectin and laminin were found in all liver plate regions 
and very little staining with anti-TN-C  antibody was ob- 
served in the adult liver (not shown). In the kidney, TN-X 
was detected in arteries  (not  shown).  The  association of 
TN-X with blood vessels in general may explain the nearly 
ubiquitous distribution observed for the TN-X mRNA. 
Discussion 
This paper represents the first study of the TN-X protein. 
The purified mouse TN-X subunit has an apparent molecular 
size of ~,500 kD. Assuming that mouse TN-X contains a ho- 
mologous NH2-terminal domain and the same number of 
EGF-like repeats as human TN-X, we can predict, after sub- 
traction of the size of these domains and of the fibrinogen 
globe, a remainder of ,'~400 kD representing the fibronectin 
type HI  repeats.  Assuming  an  average  of  10-11 kD  per 
fibronectin type HI repeat we speculate that TN-X may con- 
tain up to 36 or 40 fibronectin type HI repeats. This is consis- 
tent with the predicted protein size calculated from a 13 kb 
or larger mRNA. In the case of the human TN-X gene, 29 
fibronectin type HI repeats have already been identified, but 
it could not be excluded that more of them might be hidden 
in the gene stretches that have not been sequenced yet (3). 
Because of the presence of heptad repeats and cysteines in 
the NH2-terminal region of the human TN-X gene (3) and 
due to the fact that our purified TN-X protein did not enter 
a  gel  without  reduction,  we  assume  that  it  is  forming 
disulfide-linked oligomers as do all other tenascin family 
members. Whether TN-X is forming trimers like TN-R, hex- 
amers like TN-C, or any other type of oligomers, remains 
to be determined. 
The eDNA of mouse TN-X that we have isolated encodes 
the 3' non-coding region of  the RNA as well as the fibrinogen 
globe and the seven most COOH-terminal fibronecdn type 
HI repeats. This sequence shows an 87.1% similarity on the 
amino acid level to its human counterpart (3). Since the most 
COOH-terminal three fibronectin type HI repeats of TN-X, 
TN-C, and TN-R are arranged in a collinear fashion in front 
of  the  fibrinogen  globe,  we  compared  these  analogous 
regions among the tenascin family members. Mouse TN-X 
is in this region 89% identical to human TN-X. When mouse 
TN-X is compared to mouse TN-C (49) or rat TN-R (21) a 
sequence identity on the amino acid level of 44 and 41% can 
be  calculated,  respectively.  TN-C  and  TN-R  are  more 
closely related to each other, showing an identity of 49% 
within this  same region.  It is  thus concluded that TN-X 
diverged from a common ancestor tenascin before TN-C and 
TN-R evolved. 
Bristow et al. (3) suggested that the mouse strain aw 18, 
an intra-H-2 recombinant which is known to have a deletion 
of '~80 kb encompassing C4 and Cyp21  (45),  could be a 
mouse mutant lacking the TN-X gene. Mice homozygous for 
aw 18 die within <15 d after birth, have no Cyp21 activity, 
and  show  histopathological abnormalities  in  the  adrenal 
gland (24).  Gotoh et al. (25)  reported that aw 18 homozy- 
gous mutants can be rescued by the administration of syn- 
thetic steroids and salts. Furthermore, aw 18 transgenic mice 
Figure  11.  TN-X staining of 
blood  vessels. Sections  of 
liver  (a  and  b)  and  Peyer's 
patches of the ilium (c and d) 
were stained with hematoxilin 
(a and c) or TN-X antibody 
pAbS00 (b and d). A central 
vein surrounded by the liver 
plates  llnklns  the  space oc- 
cupied by the sinusoids  is seen 
in a and b. TN-X is found as- 
sociated with blood vessels in 
both tissues. Bars, 50 ~m. 
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motor can be rescued as well. These findings suggest that the 
aw 18 mice are clearly suffering from a deficiency of Cyp21. 
Therefore, if  TN-X was indeed essential for life, as suggested 
by Gitelman et al. (23), it could not be deleted in the aw 18 
mice. This argues that the TN-X gene in the mouse overlaps 
with Cyp21ps  rather than with Cyp21, which would mean 
that TN-X overlaps the Cyp21 gene located in the same chro- 
mosomal position as in man, namely the gene located closer 
to the centromere. Unfortunately  our data cannot clearly dis- 
tinguish between these two possibilities, because the coding 
region of TN-X is almost 100%  complementary to Cyp21, 
and the non-coding part to Cyp21ps.  This result points to- 
wards the possibility that in the Balb/c mouse a third Cyp21 
gene may exist, and/or that gene conversion has occurred. 
Either of these phenomena is well documented for humans 
(34). 
Using our antibodies against TN-X,  we found the most 
prominent expression of TN-X in skeletal and heart muscle, 
tissues where neither TN-C nor TN-R are found. The high 
expression of TN-X in muscle was already previously noted 
on the level of TN-X mRNA expression (3, 23).  Thus we 
tend to think of  TN-X as of  the muscle tenascin. In our analy- 
sis of the tissues of the digestive tract and of skin, we fre- 
quently noted intense staining for TN-C adjacent to the epi- 
thelium, whereas anti-TN-X more intensely stained regions 
further away from the epithelium in the loose mesenchyme. 
Regulation of TN-X  and  TN-C  expression,  respectively, 
seems to be completely independent within the organs ana- 
lyzed, and during the stages of major changes of TN-C ex- 
pression in oesophagus and gut, TN-X  remains constant. 
Upon rough inspection TN-X and TN-C show a reciprocal 
tissue distribution, but there is also some coexpression as, 
for example, in some of the blood vessels.  The blood vessel 
staining of TN-X in all organs analyzed is the likely reason 
for the ubiquitous expression of TN-X mRNA. Considering 
the very distinct tissue distribution of TN-X and TN-C it ap- 
pears unlikely that TN-X could compensate for the loss of 
TN-C in the mice lacking TN-C, but still we cannot exclude 
that TN-X in certain locations might replace TN-C. 
There seem to be certain common functional features of 
the tenascins.  None of them is a  very good cell adhesion 
promoting protein.  On  the contrary,  TN-C  is often con- 
sidered as an anti-adhesive or adhesion-modulating protein 
(10, 11, 43). Also, in the case of TN-X, we could not detect 
any adhesion-promoting activity for the Ren-Ca ceils (not 
shown).  Concerning binding to other extracellular matrix 
proteins, we could not find any interaction of TN-X with 
fibronectin, although TN-C is known to bind. However,  it 
should be kept in mind that only the small form of TN-C 
binds well to fibronectin (14). Thus it may be premature to 
conclude that there is no interaction possible between TN-X 
and fibronectin, since the form of TN-X produced by the 
ReCa cells may be a non-binding variant. Different splicing 
variants of TN-X may exist that could have different func- 
tions, since at least on the mRNA level we could detect two 
sizes of transcripts produced by the various cell lines ana- 
lyzed. Another known ligand of TN-C is heparin (2, 7), and 
also proteoglycans have been observed to interact with tenas- 
cin (5, 27). Furthermore, mesenchymal syndecan was shown 
to bind TN-C via its heparan-sulfate side chains (44). Since 
indeed also TN-X is binding to heparin, the possibility exists 
that this is an important functional activity that has been con- 
served among different tenascins. The heparin-binding re- 
gion of TN-C has been localized to the COOH-terminal part 
including the last three fibronectin type HI repeats and the 
fibrinogen domain (7).  Using recombinant tenascin frag- 
ments  produced  in  E.  coli  Aukhil  et  al.  (2)  found two 
heparin-binding sites,  one of them in the fourth and fifth 
fibronectin type HI repeat the other one in the fibrinogen do- 
main (2).  Since we have no evidence for a second heparin- 
binding region in fragments of authentic TN-C, we consider 
the heparin-binding activity detected in the fibronectin type 
HI repeats as a potential cryptic site revealed in the recom- 
binant fragment. We therefore believe that the heparin-bind- 
ing region of tenascin-C is located in the fibrinogen globe, 
which is the most conserved region among all members of 
the tenascin family. It is therefore possible that also in TN-X 
the fibrinogen globe is containing the heparin binding site. 
Further studies will be necessary to determine the entire 
primary structure of  TN-X, and biochemical and biophysical 
investigations should aid in revealing its oligomer structure. 
Also a more detailed description of  its tissue distribution, in- 
cluding earlier developmental stages will be of interest. At 
present we do not know anything about the function of TN-X 
in vivo, but there is circumstantial evidence that in humans 
TN-X may be an essential gene for life (35), thus leading to 
the most challenging task of finding the function(s) of TN-X. 
Received for publication 21 October 1993, and in revised form 4 January 
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